DocuSign, the leading electronic-signature company, has revealed its decision to implement a cost-saving restructuring plan that will result in a reduction of approximately 6% in its current workforce. The company plans to restructure by cutting around 400 positions, primarily affecting the sales and marketing teams. This strategic move aims to bolster DocuSign's financial … [Read more...] about DocuSign Announces Workforce Restructuring Plan
Investment
Emigrant Bank Names Liz Nesvold as Vice Chair
Emigrant has appointed Liz Nesvold as vice chair of Emigrant Bank and chair of Emigrant Partners, the unit that makes minority investments in registered investment advisory firms. This move comes after Nesvold's successful collaboration with Emigrant on various transactions since 2017. Trusting in Nesvold's Expertise CEO Howard Millstein expressed his excitement about … [Read more...] about Emigrant Bank Names Liz Nesvold as Vice Chair
Applied Materials Faces Disappointment in Chip Market
Applied Materials, a prominent manufacturer of semiconductor-manufacturing equipment, may experience a substantial letdown alongside other chip-related stocks in the upcoming year, as suggested by Susquehanna's analysis. Neutral Rating for Applied Materials Shares Analyst Mehdi Hosseini recently reiterated a Neutral rating for Applied Materials shares (ticker: AMAT) and … [Read more...] about Applied Materials Faces Disappointment in Chip Market
Expedia Group Stock Has Room for Growth, Airbnb Shares Have Limited Upside
According to an analyst at Evercore ISI, Expedia Group stock has more room to grow compared to Airbnb shares, which have seen solid gains this year. Expedia Upgraded to Outperform Mark Mahaney, in a research note, upgraded shares of Expedia (ticker: EXPE) to Outperform from In Line. He also increased his price target on the stock to $200 from $135. Mahaney stated that the … [Read more...] about Expedia Group Stock Has Room for Growth, Airbnb Shares Have Limited Upside
Activist Holdings
Kinnate Biopharma (KNTE) OrbiMed Advisors - Major Stakeholder OrbiMed Advisors, a leading investment firm, holds a significant stake in Kinnate Biopharma. They currently own 8,009,729 shares of this innovative clinical-stage oncology company, which accounts for 17% of the outstanding stock. On November 13, OrbiMed Advisors, in collaboration with Foresite Capital, submitted an … [Read more...] about Activist Holdings
